These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1712111)

  • 1. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
    Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
    Liu J; Wu Y; Arlinghaus RB
    Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
    McWhirter JR; Wang JY
    Mol Cell Biol; 1991 Mar; 11(3):1553-65. PubMed ID: 1705008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.
    Muller AJ; Pendergast AM; Havlik MH; Puil L; Pawson T; Witte ON
    Mol Cell Biol; 1992 Nov; 12(11):5087-93. PubMed ID: 1383690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.
    Mayer BJ; Jackson PK; Baltimore D
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):627-31. PubMed ID: 1703304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
    Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
    Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
    Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity.
    Wen ST; Van Etten RA
    Genes Dev; 1997 Oct; 11(19):2456-67. PubMed ID: 9334312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
    Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
    Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A myristoyl/phosphotyrosine switch regulates c-Abl.
    Hantschel O; Nagar B; Guettler S; Kretzschmar J; Dorey K; Kuriyan J; Superti-Furga G
    Cell; 2003 Mar; 112(6):845-57. PubMed ID: 12654250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain.
    Duyster J; Baskaran R; Wang JY
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1555-9. PubMed ID: 7533294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
    Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
    Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr phosphorylated on tyrosine 177 binds Grb2.
    Ma G; Lu D; Wu Y; Liu J; Arlinghaus RB
    Oncogene; 1997 May; 14(19):2367-72. PubMed ID: 9178913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bcr serine kinase by tyrosine phosphorylation.
    Liu J; Wu Y; Ma GZ; Lu D; Haataja L; Heisterkamp N; Groffen J; Arlinghaus RB
    Mol Cell Biol; 1996 Mar; 16(3):998-1005. PubMed ID: 8622703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.
    Cicchetti P; Mayer BJ; Thiel G; Baltimore D
    Science; 1992 Aug; 257(5071):803-6. PubMed ID: 1379745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.